<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                J Immunol. Author manuscript; available PMC 2014 March 01. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             J Immunol. 2013 March 1; 190(5): 2138&#8211;2149. doi:10.4049/jimmunol.1202801. <br />  <br />  <br />  <br />                            Live Attenuated <span id='am-85' about='obo:NCBITaxon_5661' typeof='owl:Thing obo:NCBITaxon_38574 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-86' property="rdfs:label" content="Leishmania donovani" datatype="xsd:string"></span><span id='am-87'  ></span><span id='am-88' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-90' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) donovani" datatype="xsd:string"></span>Leishmania donovani</span> p27 Gene Knockout <br />                            Parasites Are Non-pathogenic Elicit Long Term Protective <br />                            Immunity BALB/c Mice <br />                            Ranadhir Dey*,&#182;, Pradeep K. Dagur&#182;&#182;, Angamuthu Selvapandiyan#, J. Philip McCoy&#182;&#182;, <br />                            Poonam Salotra##, Robert Duncan*, Hira L. Nakhasi*,&#182; <br />                            *Division Emerging Transfusion Transmitted Diseases, Center Biologics Evaluation and <br />  <br />                            Research, Food Drug Administration, Bethesda, Maryland, 20892. USA <br />                            &#182;&#182;FlowCytometry Core, National Heart, Lung, Blood Institute, National Institutes Health, <br />                            Bethesda, MD 20892, USA <br />                            #InfectiousDiseases, Institute Molecular Medicine, 254, Okhla Industrial Estate, Phase III, New <br />                            Delhi, 110020 India <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            ##Institute   Pathology, Indian Council Medical Research, New Delhi, 110029 India <br />  <br />                            Abstract <br />                                  Leishmaniasis causes significant morbidity mortality worldwide vaccines <br />                                  available disease. Previously, shown amastigote specific protein p27 <br />                                  (Ldp27) component active cytochrome c oxidase complex L. donovani upon <br />                                  deletion gene parasite reduced virulence vivo. In study, shown that <br />                                  Ldp27&#8722;/&#8722; parasites survive 20 weeks BALB/c mice, safe an <br />                                  immunogen. Upon virulent challenge, 12 weeks post-immunized mice showed significantly lower <br />                                  parasite burden liver spleen. When mice challenged 20 weeks post immunization, <br />                                  significant reduction parasite burden suggesting long term protection by <br />                                  Ldp27&#8722;/&#8722; immunization. Immunization Ldp27&#8722;/&#8722; induced pro- anti- inflammatory <br />                                  cytokine responses activated splenocytes enhanced leishmaniacidal activity association <br />                                  NO production. Protection short long term immunized mice challenge with <br />                                  wild type parasite correlated stimulation multifunctional Th1 type CD4 CD8 T <br />                                  cells. Adoptive transfer T cells long term immunized mice conferred protection against <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  virulent challenge na&#239;ve recipient mice suggesting involvement memory T cell response in <br />                                  protection Leishmania infection. Immunization mice Ldp27&#8722;/&#8722; also <br />                                  demonstrated cross-protection <span id='am-91' about='obo:NCBITaxon_5664' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_38581 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-92'  ></span><span id='am-93' property="oboInOwl:hasRelatedSynonym" content="Leishmania tropica major" datatype="xsd:string"></span><span id='am-94' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-95' property="rdfs:label" content="Leishmania major" datatype="xsd:string"></span><span id='am-96' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) major" datatype="xsd:string"></span><span id='am-97' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Leishmania major</span> <span id='am-77' about='obo:NCBITaxon_5660' typeof='owl:Thing obo:NCBITaxon_37616 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_37617 obo:NCBITaxon_5653'><span id='am-78' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Viannia) braziliensis" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasRelatedSynonym" content="Leishmania viannia" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasRelatedSynonym" content="Leishmania brasiliensis" datatype="xsd:string"></span><span id='am-81' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-82' property="rdfs:label" content="Leishmania braziliensis" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-84'  ></span>Leishmania braziliensis</span> <br />                                  infection. Our <span id='am-171' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-172' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-173'  ></span><span id='am-174' property="rdfs:label" content="Data" datatype="xsd:string"></span><span id='am-175' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>data</span> genetically modified live attenuated Ldp27&#8722;/&#8722; parasites safe, <br />                                  induce protective immunity absence parasites provide protection against <br />                                  homologous heterologous Leishmania <span id='am-135' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-136' property="rdfs:label" content="species" datatype="xsd:string"></span><span id='am-137' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>species</span>. <br />  <br />  <br />                            Introduction <br />                                             Leishmaniasis insect vector borne disease caused protozoan parasite <br />                                             Leishmania. Approximately 350 million people worldwide living tropical subtropical <br />                                             regions threat infections. There 12 million infections worldwide <br />  <br />                            &#182; <br />                             To correspondence addressed: Hira L. Nakhasi, Ph.D., Phone: 301 827 3008, Fax: 301 480 7928, <br />                            Hira.Nakhasi@fda.hhs.gov. Ranadhir Dey, Ph.D., Phone: 301 827 2055, Fax: 301 480 7928, Ranadhir.Dey@fda.hhs.gov. <br />                            Findings study informal communication represent authors best judgment. These comments bind or <br />                            obligate FDA. <br />                             Dey et al.                                                                                           Page 2 <br />  <br />  <br />                                         ~2 million new clinical cases reported annually estimated death toll ~50,000 <br />                                         persons/year (1). The clinical manifestation leishmaniasis depends infecting <br />                                         Leishmania species host factors range mild cutaneous leishmaniasis <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         (CL) potentially fatal visceral leishmaniasis (VL) (2&#8211;4). VL major health <br />                                         problems Indian subcontinent, East Africa Latin American countries <br />                                         (5&#8211;7). Available drugs toxic, emergence drug resistant parasites well <br />                                         co-infection HIV make drug treatment regime complex (8). Currently <br />                                         vaccines Leishmania infections human. In leishmaniasis, host <br />                                         defense intracellular Leishmania cell mediated, involves Th1 responses due <br />                                         T-cells primed dendritic macrophage cells producing IL-12 (9&#8211;12). <br />                                         Production IL-12 antigen presenting cells IFN&#947; T cells crucial for <br />                                         controlling parasite growth enhancing nitric oxide generation (13). The Th2 <br />                                         cytokines, mainly IL-10, suppress host immunity help parasite survival (13&#8211;14), <br />                                         IL-10 protects host tissue damage excessive inflammatory <br />                                         cytokines (15). Unlike cutaneous leishmaniasis, Th1/Th2 dichotomy clear in <br />                                         visceral infection mice human VL (16). The immune response and <br />                                         pathology visceral leishmaniasis complex involving number genetic cellular <br />                                         factors process susceptibility resistance parasites (17). <br />  <br />                                         In past years, approaches tested Leishmania vaccine development <br />                                         DNA vaccination, subunit vaccination heat killed parasite vaccination and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         adjuvant (8, 18&#8211;19). Some worked animal models have <br />                                         successful far humans. Leishmanization, process deliberate infections <br />                                         Leishmania major cause controlled skin lesion low number parasites has <br />                                         shown provide protection reinfection (20&#8211;21). Immunity be <br />                                         acquired pre-exposure infection demonstrated individuals migrated <br />                                         L. major endemic region reactive Leishmania antigen, lower risk <br />                                         developing VL (22&#8211;23). Therefore, studies suggest effective vaccine <br />                                         leishmaniasis controlled parasitic infection provide complete array of <br />                                         antigens wild type parasite necessary developing protective immune <br />                                         response. Past experience pathogens suggested live attenuated pathogens <br />                                         fulfill requirement (24&#8211;26) <br />  <br />                                         Attempts develop live attenuated Leishmania vaccine, including chemical mutagenesis, <br />                                         long-term serial vitro cultures, irradiation, temperature sensitivity targeted gene <br />                                         deletions alleles past (18, 27&#8211;33). However, the <br />                                         mutated parasite cell lines developed species causing cutaneous leishmaniasis, such <br />                                         L. major L. mexicana. Attempts using partial targeted gene deleted <br />                                         parasites A2-A2rel gene cluster L. donovani (34) SIR2 gene L. infantum <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         (35) test immunogens. However, mutants developed VL causing parasites <br />                                         used vaccine candidates carry single alleles wild type <br />                                         gene revert wild genotype regain virulence. Therefore critical to <br />                                         develop attenuated parasites complete gene knockouts alleles a <br />                                         virulence gene non-functional capable reversion cause disease. L. <br />                                         donovani biopterin transporter (BT1) null mutant parasites alleles disrupted were <br />                                         tested mice showing reduced infectivity induced protection infection with <br />                                         wild type parasites (36). However study did address issue safety and <br />                                         correlates immune protection genetically modified live attenuated L. donovani <br />                                         parasites. To address question, previously developed amastigote specific <br />                                         replication deficient Centrin gene deleted L. donovani parasite cell line (LdCen&#8722;/&#8722;) was <br />                                         tested rodent model, limited persistence induce protective <br />                                         cellular immune response immunized animals (37). Recently, developed L. <br />                                         donovani cell line devoid p27 gene, encoding amastigote specific cytochrome c <br />  <br />  <br />                                              J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                              Page 3 <br />  <br />  <br />                                          oxidase component (38) demonstrated Ldp27&#8722;/&#8722; parasites persist longer (&gt; 12 <br />                                          weeks) compared LdCen&#8722;/&#8722; (5 weeks) mice (37&#8211;38). We evaluated whether <br />                                          longer persistence Leishmania antigens produce better protection. In current study <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          showed Ldp27&#8722;/&#8722; parasite cell line, persist extended period of <br />                                          time causing pathogenesis, elicit effective cell mediated effector protective <br />                                          immune response homologous heterologous Leishmania species. <br />  <br />                               Materials Methods <br />                               Animals parasites <br />                                          Five week old female BALB/c mice National <span id='am-104' about='obo:NCBITaxon_6754' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_72041 obo:NCBITaxon_33154 obo:NCBITaxon_6681 obo:NCBITaxon_6682 obo:NCBITaxon_6683 obo:NCBITaxon_29964 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_116706 obo:NCBITaxon_116704 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_6692 obo:NCBITaxon_1206794 obo:NCBITaxon_6657 obo:NCBITaxon_6753 obo:NCBITaxon_88770 obo:NCBITaxon_6752'><span id='am-105' property="rdfs:label" content="Cancer" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-107'  ></span><span id='am-108' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Cancer</span> Institute, Bethesda, MD <br />                                          used experiments. Procedures used reviewed approved Animal <br />                                          Care Use Committee, Center Biologics Evaluation Research, Food Drug <br />                                          Administration. Among parasites, wild type (Wt) L. donovani (Ld1S) maintained in <br />                                          Golden Syrian hamsters p27 gene deleted (Ldp27&#8722;/&#8722;) L. donovani (Ld1S2D) (38) <br />                                          used. The parasites cultured according procedure previously described (39&#8211; <br />                                          40). Leishmania major (Friedlin) L. braziliensis promastigotes grown 26&#176;C in <br />                                          medium 199 supplemented (M199/S) 20% fetal calf serum. <br />  <br />                               Immunizations challenge studies <br />                                          The mice immunized tail vein 3 &#215; 106 stationary phase Ldp27&#8722;/&#8722; parasites. In <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          study 4 5 mice used group. Immunized mice challenged different <br />                                          time periods immunization tail vein 105 stationary phase Wt L. donovani <br />                                          parasites. Age matched na&#239;ve mice controls similarly challenged 105 <br />                                          virulent stationary phase Wt L. donovani parasites. In separate experiments, mice <br />                                          immunized (with Ldp27&#8722;/&#8722;) (na&#239;ve saline) challenged injecting s. <br />                                          c./ i. d. left hind footpad 105 stationary phase L. major 106 stationary phase L. <br />                                          braziliensis parasites. After various periods post challenge, parasite load measured from <br />                                          spleens livers L. donovani challenged mice footpads lymph <br />                                          nodes L. major L. braziliensis challenged mice limiting dilutions as <br />                                          previously described (41). As additional confirmation presence parasites in <br />                                          tissues, total DNA obtained spleens mice certain groups specified the <br />                                          results used template real-time PCR. The real-time PCR based the <br />                                          target kinetoplast minicircle DNA using primers methods described (42). <br />  <br />                                          For immune-suppression study, mice infected Wt Ldp27&#8722;/&#8722; parasites, <br />                                          20 weeks 25 weeks post-infection 2 mg/kg Dexamethasone sodium phosphate (Sigma <br />                                          Aldrich) PBS administered subcutaneously 3 times week (43). At end <span id='am-130' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-131' property="rdfs:label" content="This" datatype="xsd:string"></span><span id='am-132'  ></span><span id='am-133' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-134' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>this</span> <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          treatment mice sacrificed evaluated parasite burden visceral organs. <br />  <br />                               Multiplex Cytokine ELISA <br />                                          Single cell suspensions prepared splenocytes lysis red blood cells by <br />                                          using Ammonium-Chloride-Potassium (ACK) lysing buffer (Lonza, MD, USA). Cells were <br />                                          washed medium plated 24 plates stimulated freeze-thaw L. <br />                                          donovani antigen (FTAg) Ag complete RPMI 1640 medium 37&#176;C 5% <br />                                          CO2 95% humidity incubator. After 72 hours culture cell supernatants were <br />                                          collected stored &#8722;80&#176;C analyzed using multiplex kits, Milliplex Mouse <br />                                          Cytokine/ Chemokine Magnetic Panel Millipore, USA plate read a <br />                                          Luminex -100&#8482; (Luminex, Austin, USA) using Bioplex manager software 5.0. The <br />                                          cytokine analysis procedure performed according manufacturer&#8217;s instructions <br />                                          level cytokine concentration determined using standard curve each <br />                                          specific cytokine. <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                           Page 4 <br />  <br />  <br />                               Intracellular staining flow cytometry <br />                                           Splenocytes plated 24-well plates complete RPMI medium 37&#176;C and <br />                                           stimulated FTAg (80&#956;g/ml) (44). After 48 hrs 37&#176;C Protein Transport <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Inhibitor (BD Golgi Stop, BD Pharmingen) added wells. Six hours cells <br />                                           blocked 4&#176;C Rat anti mouse CD16/32 (5&#956;g/ml) BD Pharmingen 20 <br />                                           minutes. Cells surface stained anti mouse CD3 APC-eFluor@780, anti mouse <br />                                           CD4 eFluor@450, anti mouse CD8a eFluor@605NC, anti mouse CD44 FITC, anti <br />                                           mouse CCR7 PE-Cy5 antibodies (eBioscience, USA) 30 min (each 1:200 dilution; <br />                                           4&#176;C). The cells stained Live/Dead Fixable Aqua (Invitrogen, Molecular <br />                                           Probes) stain dead cells. Cells washed wash buffer fixed Cytofix/ <br />                                           Cytoperm kit (BD Bioscience) 20 min (room temperature). Intracellular staining was <br />                                           anti mouse IFN&#947; PE-Cy7, anti mouse TNF&#945; PerCp-eFluor@710, anti mouse IL-2 <br />                                           APC anti mouse IL-10 PE (eBioscience, USA) 30 min (each 1:300 dilution; <br />                                           4&#176;C). Cells acquired LSRII (BD Biosciences, USA) equipped 405, 488, 532, <br />                                           638 <span id='am-160' about='obo:NCBITaxon_62990' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_364270 obo:NCBITaxon_131567 obo:NCBITaxon_241799 obo:NCBITaxon_91882 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_241789 obo:NCBITaxon_4037 obo:NCBITaxon_241778 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_4036 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71274 obo:NCBITaxon_3193'><span id='am-161' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-162'  ></span><span id='am-163' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-164' property="rdfs:label" content="Laser" datatype="xsd:string"></span>laser</span> lines using DIVA 6.1.2 software. Data analyzed FlowJo <br />                                           software version 9.1.5 (Treestar, San Carlos, CA). For analysis, doublets removed <br />                                           using width parameter; dead cells excluded based staining Live/Dead Aqua <br />                                           dye. Lymphocytes identified according light-scattering properties. CD4 and <br />                                           CD8 T-cells identified CD3+ lymphocytes uniquely expressing CD4 CD8. <br />                                           Upon gating intracellular cytokines measured CD44Hi CCR7Low cells. FMO <br />                                           controls used proper gating positive events designated cytokines. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Antibody responses <br />                                           Specific antibody responses measured conventional enzyme-linked <br />                                           immunoadsorbent assay (ELISA). Briefly, ELISA plates coated overnight room <br />                                           temperature FTAg (15&#956;g/ml). A serial dilution sera carried determine <br />                                           titer, defined inverse highest serum dilution factor giving an <br />                                           absorbance &gt;0.2. The titers antibodies determined using following <br />                                           horseradish peroxidase-conjugated secondary antibodies: Rabbit anti-mouse IgG (H+L)- <br />                                           HRP; Rabbit anti-mouse IgG1-HRP, Rabbit anti-mouse IgG2a-HRP; Southern Biotech, <br />                                           Birmingham, AL; 1:1000 dilutions). SureBlue&#8482; (KPL, Gaithersburg, MD) used <br />                                           peroxidase substrate. After 15 min, reaction stopped addition 100 &#956;l <br />                                           1M H2SO4, absorbance read 450 nm. <br />  <br />                               Histological staining <br />                                           Mouse livers fixed fixative solutions (10% buffered formalin phosphate solution), <br />                                           sent Histoserv, Gaithersburg, MD USA sectioning H&amp;E staining. Stained <br />                                           sections analyzed microscope (Nikon Eclipse TE2000-U). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               NO quantification <br />                                           Splenocytes macrophages obtained peritoneal fluid (45) cultured complete <br />                                           RPMI medium presence absence FTAg 24 h 37&#176;C. NO (nitrite/nitrate) <br />                                           production determined supernatants cultures Griess reaction kit <br />                                           (Sigma-Aldrich Corporation, St-Louis, MO) (37). <br />  <br />                               CFSE proliferation assay <br />                                           Proliferative capacity T cells assessed CFSE dilution assay Ldp27&#8722;/&#8722; <br />                                           immunized mice challenge wild type parasites (46). Age matched <br />                                           na&#239;ve mice served negative controls Ag-specific proliferation. Splenocytes from <br />                                           different groups mice isolated, incubated 5&#956;M CFSE (Molecular Probes/ <br />                                           Invitrogen) 10 min RPMI 1640 fetal calf serum (FCS) followed 5 min of <br />  <br />  <br />                                                J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                                 Page 5 <br />  <br />  <br />                                            quenching ice-cold RPMI1640 plus 10% FCS subsequently washed thoroughly <br />                                            plating 96 tissue culture plates 2 &#215; 105 cells/well. Cells cultured 5 <br />                                            days 37&#176;C 5% CO2 stimulation FTAg (50&#956;g/ml). Cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            harvested, washed blocked anti-CD16/32 (5&#956;g/ml) 20 min (4&#176;C), <br />                                            cell surface stained anti mouse CD3 APC-eFluor@780, anti mouse CD4 eFluor@450, <br />                                            anti mouse CD8a eFluor@605NC (eBioscience, USA) 30 min (each 1:200 dilution; <br />                                            4&#176;C). Cells acquired LSRII (BD Biosciences, USA) equipped 405, 488, 532, <br />                                            638 laser lines using DIVA 6.1.2 software. Data analyzed FlowJo <br />                                            software version 9.1.5. <br />  <br />                               Adoptive cell transfer <br />                                            Total T cells, CD4 CD8 T cells mice 16 weeks post-immunization Ldp27&#8722;/&#8722; <br />                                            non-immunized na&#239;ve mice isolated transferred na&#239;ve mice. Purification of <br />                                            T cells performed Midi-MACS (Miltenyi Biotec, USA) using <span id='am-122' about='obo:NCBITaxon_9596' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_9526 obo:NCBITaxon_9604 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314146 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_314293 obo:NCBITaxon_314295 obo:NCBITaxon_376913 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_207598 obo:NCBITaxon_9443'><span id='am-123' property="rdfs:label" content="Pan" datatype="xsd:string"></span><span id='am-124' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-125' property="oboInOwl:hasExactSynonym" content="chimpanzees" datatype="xsd:string"></span><span id='am-126' property="oboInOwl:hasAlternativeId" content="NCBITaxon:317028" datatype="xsd:string"></span><span id='am-127' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-128'  ></span><span id='am-129' property="oboInOwl:hasAlternativeId" content="NCBITaxon:445518" datatype="xsd:string"></span>Pan</span>-T <br />                                            cells, CD4 T cells CD8 T cells isolation kits, respectively recommended the <br />                                            manufacturer. 5 &#215; 106 total T cells CD4 CD8 T cells transferred recipient mice <br />                                            24 hrs later groups mice infected L. donovani Wt parasites. The purity <br />                                            isolated T cells population &gt; 95% observed flow cytometry. <br />  <br />                               Statistical analysis <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Statistical analysis differences means groups determined unpaired two <br />                                            tailed &#8216;Student t test&#8217; using Graph Pad Prism 5.0 software. A p value 0.05 was <br />                                            considered significant p value 0.01 considered highly significant. <br />  <br />                               Results <br />                               Live attenuated Ldp27&#8722;/&#8722; parasites disseminate visceral organs limited <br />                               persistence non pathogenic <br />                                            We previously demonstrated Ldp27&#8722;/&#8722; mutant unable sustain 13 weeks <br />                                            post-infection defect overcome episomal expression p27 Ldp27&#8722;/&#8722; cell <br />                                            line (38). To dissect organ specific survival Ldp27&#8722;/&#8722; parasites, mice were <br />                                            injected intravenously stationary phase wild type (Wt) Ldp27&#8722;/&#8722; promastigotes and <br />                                            parasite burden measured spleen liver 4, 8 16 weeks post- <br />                                            infection (Figure 1A &amp; B). The parasite burden significantly high spleen the <br />                                            liver Wt infected mice 16th week reflecting normal course infection. <br />                                            However, Ldp27&#8722;/&#8722; mutants showed progressive decline 4 weeks post-infection in <br />                                            spleen liver. In time points, 4 8 weeks post-infection, Ldp27&#8722;/&#8722; infected <br />                                            mice significantly (p&lt; 0.05) parasite burden compared Wt infected mice both <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            organs (Figure 1A &amp; B). Interestingly, Ldp27&#8722;/&#8722; infected mice 16th week, the <br />                                            parasites cleared organs, recover live parasites from <br />                                            serial dilutions cultured organ cell suspension mice. Similar results obtained <br />                                            confirmatory real-time PCR study using DNA spleens mice infected with <br />                                            Wt Ldp27&#8722;/&#8722; parasites (supplementary Table 1). Detection parasite specific <br />                                            minicircle DNA target indicated presence substantial number parasites Wt- <br />                                            infected (12 weeks) Ldp27&#8722;/&#8722; infected (12 weeks) mice. However, 20 weeks after <br />                                            infection Ldp27&#8722;/&#8722;, mice longer detectable parasites was <br />                                            significant parasite burden Wt-infected spleens, suggesting absence residual <br />                                            attenuated parasite persistence. Taken experiments suggested deletion of <br />                                            Ldp27 gene does affect visceralizing capacity cell line, the <br />                                            parasite growth severely impaired host organs leading clearance host. <br />  <br />  <br />  <br />  <br />                                                  J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                             Page 6 <br />  <br />  <br />                                           To rule survival undetectable Ldp27&#8722;/&#8722; mutant parasites visceral organs <br />                                           20 weeks post-infection, treated Wt Ldp27&#8722;/&#8722; parasite infected mice with <br />                                           Dexamethasone (DXM), known immune-suppressor allow proliferation residual <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           parasites. In Wt-infected group, treatment DXM enhances parasite growth the <br />                                           spleen (Figure 1C) liver (data shown) 20 weeks 25 weeks infection. In <br />                                           Ldp27&#8722;/&#8722; infected mice 20 weeks post-infection, 2 12 (16%) mice showed a <br />                                           low number parasites spleen liver. However, 25 weeks post- <br />                                           infection, DXM treatment did observe Ldp27&#8722;/&#8722; parasites the <br />                                           spleen, liver bone marrow. These observations confirm Ldp27&#8722;/&#8722; safe an <br />                                           immunogen does persist long term. <br />  <br />                                           To ensure Ldp27&#8722;/&#8722; cause pathogenesis analyzed histopathology the <br />                                           liver. Stained liver sections (Figure 1D) showed initially (6 weeks post infection) <br />                                           Ldp27&#8722;/&#8722; parasites generated inflammatory response resulting development of <br />                                           inflammatory foci. Unlike Wt-infected mouse liver, inflammatory foci were <br />                                           devoid parasites Ldp27&#8722;/&#8722; infected mice. Moreover, later stage infection (16 <br />                                           weeks post-infection) Ldp27&#8722;/&#8722; infected mouse liver completely free any <br />                                           inflammatory foci liver cells showed normal morphology. On contrary the <br />                                           wild type L. donovani infected mouse liver, inflammatory foci, <br />                                           foci free parasites. These observations confirm Ldp27&#8722;/&#8722; <br />                                           causes initial mild pathogenesis host liver, eventually host clears the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           parasite restores normal architecture liver tissue. <br />  <br />                               Immunization Ldp27&#8722;/&#8722; protects challenge virulent L. donovani <br />                                           To determine protective efficacy Ldp27&#8722;/&#8722; immunization, na&#239;ve BALB/c mice were <br />                                           immunized Ldp27&#8722;/&#8722; parasites saline intravenous injection. Twelve weeks <br />                                           post-immunization mice challenged wild type L. donovani parasites and <br />                                           assessment parasite burden spleens livers time points post- <br />                                           challenge, measured limiting dilution. The results showed immunization Ldp27&#8722;/&#8722; <br />                                           significantly reduces liver spleen parasite burden 4, 8 12 weeks post-challenge <br />                                           compared non-immunized mice group (Figure 2A B). However 12 weeks post- <br />                                           challenge, immunized mice showed significant protection having 2.5 log 4 log <br />                                           fold reduction parasite number liver spleen respectively compared non- <br />                                           immunized mice (Figure 2A &amp; B). Non-immunized infected mice showed significant <br />                                           splenomegally compared immunized infected mice (data shown). To evaluate the <br />                                           ability Ldp27&#8722;/&#8722; immunization confer long-term protection, mice challenged with <br />                                           virulent L. donovani parasites 20 weeks following Ldp27&#8722;/&#8722; immunization, parasite <br />                                           load evaluated 12 weeks post-challenge (Fig 2C). There significant reduction in <br />                                           parasite burden spleen liver mice challenged 20 weeks post-immunization <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           compared na&#239;ve challenged mice (Fig. 2C). However reduction parasite burden was <br />                                           20 weeks post-immunization group (2 log fold spleen 1.5 log fold liver) <br />                                           12 week immunized group (4 log fold spleen 2.5 log fold liver, <br />                                           compare data Figure 2A &amp;B Figure 2C). Overall data suggest Ldp27&#8722;/&#8722; <br />                                           immunization confers significant sustained protection 20 weeks post-immunization. <br />  <br />                               Ldp27&#8722;/&#8722; immunization induces mixed pro-inflammatory anti-inflammatory cytokine <br />                               response virulent challenge <br />                                           To characterize immune response induced live attenuated Ldp27&#8722;/&#8722; parasites, we <br />                                           analyzed antigen-specific cytokine secretion splenocytes na&#239;ve, immunized, non- <br />                                           immunized challenged immunized challenged mice. There significant induction <br />                                           Leishmania antigen specific IFN&#947; IL-12p70 secretion splenocyte culture <br />                                           supernatants 12 weeks post-immunized mice (Figure 3). IFN&#947; TNF&#945; also <br />  <br />  <br />                                                J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                              Page 7 <br />  <br />  <br />                                           induced 20 weeks post-immunized mice (Figure 3). Interestingly, following 3 weeks of <br />                                           challenge wild type L. donovani parasites, 12 weeks post-immunized mice showed <br />                                           significantly enhanced IFN&#947;, TNF&#945; IL-12 secretion 20 weeks post-immunized <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mice showed significantly enhanced IFN&#947; IL-12, TNF&#945; secretion compared to <br />                                           non-immunized challenged mice. In 12 weeks post-immunized challenged mice there <br />                                           significant induction anti inflammatory cytokines like IL-10, IL-4 IL-13 <br />                                           compared na&#239;ve challenged. Although significant induction IL-10 secretion <br />                                           20 weeks post-immunized mice immunized challenged mice compared non- <br />                                           immunized challenged mice; difference levels IL-4 IL-13 20 <br />                                           week immunized challenged mice. Overall results suggest Ldp27&#8722;/&#8722; parasite <br />                                           immunization primes selective long-term mixed pro anti-inflammatory immune <br />                                           response wild type parasites. <br />  <br />                               Resistance infection induced Ldp27&#8722;/&#8722; immunization associated induction of <br />                               Nitric Oxide splenocytes <br />                                           Most pro-inflammatory cytokines activate macrophages induce NO production. <br />                                           NO macrophage derived effector molecules crucial control of <br />                                           intracellular Leishmania infections (47). A significant Leishmania antigen <br />                                           specific nitrite production observed 12 weeks 20 weeks post- <br />                                           immunized mice compared non-immunized mice splenocytes (Figure 4). However a <br />                                           greater NO observed Ldp27&#8722;/&#8722; immunized mice wild type L. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           donovani challenge compared na&#239;ve challenged 12 20 weeks post-immunized <br />                                           mice (Figure 4). Interestingly induction nitrite concentration similar challenged <br />                                           animals immunized 12 20 weeks. Overall, sustained nitrite secretion level by <br />                                           splenocytes indicates pro-inflammatory cytokine dominating milieu immunized mouse <br />                                           spleens turn favors host clearing parasites. <br />  <br />                               Immunization Ldp27&#8722;/&#8722; induces sustained level Ag-specific T cell proliferation <br />                               response <br />                                           Impairment cell mediated immune response hallmark active VL humans or <br />                                           animals (48). Restoration antigen specific immune response crucial effective <br />                                           vaccine induced immunity. To investigate proliferative potential reencounter a <br />                                           Leishmania antigen, spleen cells isolated na&#239;ve; na&#239;ve challenged, 20 weeks post- <br />                                           immunized immunized challenged mice. Splenocytes CFSE labeled stimulated <br />                                           vitro FTAg medium alone. After 5 days Ag stimulation, cells stained <br />                                           anti-CD3, anti-CD4 anti CD8 antibodies, CFSE profile analyzed with <br />                                           flow-cytometer (Figure 5A). FlowJo analysis showed CD3+ T cells including <br />                                           CD4 CD8 isolated mice immunized Ldp27&#8722;/&#8722; significantly higher <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           proliferative capacity response Leishmania FTAg antigen compared T cells isolated <br />                                           na&#239;ve mice (Figure 5B). Further, T cells isolated mice immunized challenged <br />                                           virulent L. donovani parasites significantly (p&lt; 0.05) higher proliferative capacity <br />                                           na&#239;ve challenged group (Figure 5B). The significant proliferative capacity T cells <br />                                           20 weeks post-immunized mice, suggests derived from <br />                                           memory response. <br />  <br />                               Induction multifunctional antigen experienced Th1 effector cells correlates with <br />                               Ldp27&#8722;/&#8722; induced immunity <br />                                           Having shown immunization Ldp27&#8722;/&#8722; parasite establishes stable, long- <br />                                           lived immunological protection wild type Leishmania parasite, subsequently <br />                                           characterized phenotype cytokine production antigen experienced effector <br />                                           memory T cells CD44HI/CCR7Low 20 weeks post-immunized animals (49&#8211;50). Using <br />                                           intracellular FACS staining, antigen experienced CD4 CD8 T cells gated based on <br />  <br />                                                J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                         Page 8 <br />  <br />  <br />                                         surface expression CD44 CCR7 (Figure 6A). The CD44HI/CCR7Low cells were <br />                                         separated seven distinct subpopulations based production IFN&#947;, TNF&#945; or <br />                                         IL-2 combination pool effector memory T cells (Figure 6A). The results <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         showed 20 weeks post-immunization, CD4 T cells, IFN&#947; single cytokine secreting cells <br />                                         dominating substantial number single IL-2 TNF&#945;+ producing as <br />                                         double IFN&#947;+ IL-2+ IFN&#947;+ TNF&#945;+ producing cells (Figure 6B). In CD8 T cells, <br />                                         IFN&#947;+ cells dominating, significant number IL-2 TNF&#945;+ <br />                                         single producing cells double cytokine producing IFN&#947;+IL-2+, IFN&#947;+TNF&#945;+, <br />                                         TNF&#945;+IL-2+ triple cytokines producing IFN&#947;+TNF&#945;+IL-2+ cells (Figure 6C). Most <br />                                         importantly CD8 T cell compartment higher percentage double triple <br />                                         cytokine producing cells CD4 T cells compartment (Figure 6C vs Figure 6B). <br />  <br />                                         Having shown Ldp27&#8722;/&#8722; immunization induces long-term immune response <br />                                         characterized high level multifunctional CD4 CD8 T cells, characterized the <br />                                         nature immune response challenge wild type parasite. In CD4 CD8 <br />                                         T cells spleens 12 weeks 20 weeks post-immunized challenged mice, <br />                                         IFN&#947; cytokine secreting cells significantly higher non-immunized <br />                                         challenged mice (Figure 7A&#8211;D). In addition, significantly higher percentage double or <br />                                         triple cytokine producing CD4 (Figure 7A &amp; B) CD8 (Figure 7C &amp; D) T cells were <br />                                         observed cytokines 12 weeks 20 weeks post-immunized and <br />                                         challenged mice compared non-immunized challenged mice. Particularly, CD4 T cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         IFN&#947;+ IL-2+, IFN&#947;+ TNF&#945;+ IFN&#947;+ IL-2+ TNF&#945;+ producing cells significantly <br />                                         higher 12 weeks post-immunized challenged mice. Similarly, 20 weeks <br />                                         immunized-challenged mice TNF&#945;+ IL-2+ IFN&#947;+ IL-2+ TNF&#945;+ cells higher <br />                                         compared non-immunized challenged mice. Albeit percentage cells was <br />                                         smaller compared 12 weeks post-immunized challenged mice. Interestingly, 20 <br />                                         week immunized mice, percentage double triple cytokine producing CD8 T <br />                                         cells higher compared CD4 T cells similar results observed immunized mice <br />                                         challenge. Overall results indicate Ldp27&#8722;/&#8722; immunized mice induce a <br />                                         strong antigen experienced effector memory T cell mediated immune response 20 <br />                                         weeks post-immunization time point majority mice cleared Ldp27&#8722;/&#8722; <br />                                         parasite. <br />  <br />                                         We quantified antigen experienced CD4 CD8 T cells produce IL-10, crucial <br />                                         anti-inflammatory cytokine pathogenesis VL (16, 37, 51). In antigen stimulated <br />                                         CD4 CD8 T cells spleen, IFN&#947;/ IL-10 ratio significantly higher the <br />                                         12ws immunized mice challenge compared non-immunized challenged mice (Figure <br />                                         8A). These results indicate increased IFN&#947; secretion simultaneously decreased <br />                                         IL-10 production antigen experienced CD4 CD8 T cells results strong Th1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         response translate protective immunity. In addition IL-10 shown to <br />                                         critical immune-regulatory molecule necessary shape amplitude immune <br />                                         response prevent infection associated lesions (15, 52). Particularly, IFN&#947; and <br />                                         IL-10 coproducing cells play important role prevent collateral tissue damage an <br />                                         extensive inflammatory cytokines (52). We analyzed percentage IFN&#947; and <br />                                         IL-10 coproducing antigen experienced CD4 CD8 T cells. In mice challenged <br />                                         12ws post-immunization significantly higher percentage CD4 and <br />                                         CD8 T cells positive IFN&#947; IL-10 compared na&#239;ve challenged mice <br />                                         (Figure 8B). Interestingly, percentage IFN&#947;/IL-10 coproducing CD8 T cells was <br />                                         significantly higher coproducing CD4 T cells. Overall data clearly indicate <br />                                         Ldp27&#8722;/&#8722; immunization induces host protective cell mediated controlled <br />                                         proinflammatory immune response challenge wild type infection. <br />  <br />  <br />  <br />  <br />                                              J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                              Page 9 <br />  <br />  <br />                               Adoptive transfer isolated T cells Ldp27&#8722;/&#8722; immunized mice confers protection to <br />                               recipient mice <br />                                           To confirm T cell mediated immunity sufficient protect wild type parasite <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           infection, performed adoptive transfer T cells. The recipient mice infected with <br />                                           wild type parasites 10 weeks parasite load measured. Mice received T cells <br />                                           immunized mice showed significant reduction parasite burden compared to <br />                                           recipients T cells non-immunized mice. There 4 log fold, 2 log fold 3.5 log <br />                                           fold reduction parasite burden spleens recipients Ldp27&#8722;/&#8722; immunized total T <br />                                           cells, CD4 T cells CD8 T cells respectively compared mice receiving non-immunized <br />                                           T cells (Figure 9). These results clearly indicate attenuated parasite induced immunity is <br />                                           T cell mediated immunity CD4 CD8 T cells major effector T-cell <br />                                           populations important controlling parasite burden immunized mice. <br />  <br />                               Ldp27&#8722;/&#8722; immunization cross protects mice challenge Leishmania <br />                               species <br />                                           We investigated immunization Ldp27&#8722;/&#8722; provide protection <br />                                           heterologous species Leishmania. Mice immunized (i. v.) Ldp27&#8722;/&#8722; parasites <br />                                           12 weeks infected (in footpad) L. major L. braziliensis. The na&#239;ve <br />                                           mice infected L. major started developing progressive lesions 3 weeks post- <br />                                           challenge weeks post challenge developed large swollen footpad with <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           lesions. On contrary, Ldp27&#8722;/&#8722; immunized mice developed significantly smaller lesions <br />                                           compared na&#239;ve mice did continue swell (Figure 10A). The immune- <br />                                           challenged mice showed significantly lower parasite burden footpads and <br />                                           lymph nodes compared na&#239;ve challenged mice (Figure 10B). Similarly a <br />                                           significantly reduced footpad swelling compared non-immunized mice Ldp27&#8722;/&#8722; <br />                                           immunized mice infection L. braziliensis, (Figure 10C). The parasite burden the <br />                                           footpad draining lymph nodes significantly reduced immunized mice <br />                                           compared non-immunized mice (Fig. 10D). These results suggest immunization live <br />                                           attenuated L. donovani parasites control parasitemia non visceralizing Leishmania <br />                                           infections. <br />  <br />                               Induction humoral response immunized mice <br />                                           Although specific evidence role Leishmania specific antibodies in <br />                                           determining outcome VL (53), dominance immunoglobulin subtype one <br />                                           predict outcome immune response vivo. Mouse sera assessed L. <br />                                           donovani specific IgG1 IgG2 isotypes, surrogate markers Th2 Th1 CD4 T cell <br />                                           differentiation respectively. In Ldp27&#8722;/&#8722; immunized mice levels IgG2a IgG1 were <br />                                           significantly different 8 weeks post infection. However, IgG2a levels were <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           progressively higher 12 16 weeks post-immunization groups mice (Figure S1A), <br />                                           correlated clearance Ldp27&#8722;/&#8722; parasites visceral organs (Fig. <br />                                           1AB). On contrary mice infected Wt parasites, IgG2a/ IgG1 ratio lower, <br />                                           suggesting Th2 type immune response correlates disease progression is <br />                                           evident increased parasite burden (Figure 2AB). Interestingly, 20 weeks post- <br />                                           immunized challenged mice IgG2a/ IgG1 ratio significantly higher non- <br />                                           immunized challenged mice, suggesting host protective Th1 type immune response <br />                                           (Figure S1B). The increased serum IgG2a levels observed immunized challenged <br />                                           mice correlate increased Th1 response. <br />  <br />                               Discussion <br />                                           In Leishmania infection, individuals recover natural infection protected from <br />                                           reinfection develop life-long protection, suggesting infection prerequisite <br />  <br />                                                J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                            Page 10 <br />  <br />  <br />                                         immunological memory. The genetically altered live-attenuated parasites controlled <br />                                         infectivity achieve immunological memory (37). In addition, live attenuated <br />                                         parasites provide broad spectrum parasite antigens generate diverse antigen <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         specific memory immune response important protection infection. Live <br />                                         attenuated vaccination old widely accepted method broad spectrum of <br />                                         diseases like bacille Calmette-Guerin (BCG), polio vaccine, small pox, (24&#8211;25). In this <br />                                         study evaluated safety potency Leishmania live attenuated vaccine candidate, <br />                                         Ldp27&#8722;/&#8722; parasite homologous heterologous Leishmania species. We observed <br />                                         host protection correlates induction Leishmania antigen specific cell <br />                                         mediated immune response. <br />  <br />                                         Safety live attenuated parasites vaccine essential parasites not <br />                                         regain virulence used human immunogens. Therefore tested Ldp27&#8722;/&#8722; <br />                                         parasites virulence mice. Ldp27&#8722;/&#8722; parasites reduced growth the <br />                                         promastigote stage however, growth attenuated intracellular amastigote <br />                                         stage. These parasites visceralize spleen liver mice cleared 20 <br />                                         weeks infection demonstrated absence parasite immune-suppressed <br />                                         mice. Six weeks immunization Ldp27&#8722;/&#8722; parasite mice recruit infiltrating <br />                                         mononuclear cells form foci liver similar wild type infection. However, these <br />                                         foci lack parasites unlike wild type infection induced foci. Furthermore, 16 weeks post- <br />                                         immunization liver cell morphology returns normal similar uninfected <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         condition. Thereby suggesting Ldp27&#8722;/&#8722; parasites safe illicit host response <br />                                         causing pathogenesis. <br />  <br />                                         The efficacy Ldp27&#8722;/&#8722; parasites immunogens confirmed significant parasite <br />                                         control immunized mice infection early late stages immunization. It is <br />                                         established literature VL control parasitemia correlated the <br />                                         induction pro anti-inflammatory cytokine response (54&#8211;55). Such correlation <br />                                         observed using Ldp27&#8722;/&#8722; parasites immunogens indicated significant enhanced <br />                                         secretion pro-inflammatory cytokines like IFN&#947;, TNF&#945; IL-12 significant <br />                                         induction anti-inflammatory cytokines like IL-10, IL-4 IL-13. However, to <br />                                         balance pro-inflammatory anti-inflammatory cytokines avoid tissue <br />                                         injury. Recent studies suggested exacerbated response infections result in <br />                                         deleterious lesion extensive tissue damage, IL-10 prevents development of <br />                                         immuno-pathological tissue damage (15). Therefore, lack liver tissue damage the <br />                                         absence splenomegaly live attenuated parasite immunized mice outcome <br />                                         induction IL-10 secretion Ldp27&#8722;/&#8722; parasite balancing effect extensive <br />                                         pro-inflammatory cytokines IFN&#947;. In addition, IL-4 IL-13 been <br />                                         shown crucial clearance L. donovani parasite liver spleen (56&#8211;58). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Therefore, enhanced IL-4 IL-13 levels observed early stage Ldp27&#8722;/&#8722; <br />                                         parasite immunization study important development hepatic <br />                                         granuloma maturation leishmaniacidal activity resulting enhanced NO production <br />                                         turn results significant reduction parasite visceral organs. Taken together <br />                                         results clearly suggest Ldp27&#8722;/&#8722; parasites induce mixed Th1 Th2 response <br />                                         causing tissue damage control parasite burden enhancing the <br />                                         leishmaniacidal activity. <br />  <br />                                         In mice, vaccine induced T cell response shown correlate protection against <br />                                         Leishmaniasis (37, 59&#8211;61). Therefore, analyzed CD4 CD8 T cells CD44HI/ <br />                                         CCR7Low populations represent antigen experienced effector memory T cells (61&#8211;62) to <br />                                         determine correlates immune protection Ldp27&#8722;/&#8722; parasites. In current study, the <br />                                         Ldp27&#8722;/&#8722; immunization induced significantly high frequency antigen experienced CD4 <br />                                         CD8 T cells detected 20 weeks post-immunization and <br />  <br />  <br />                                              J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                            Page 11 <br />  <br />  <br />                                         conferred significant level protection. In addition, significant level Ag <br />                                         specific T cell recall response indicated T cell proliferation 20 weeks post- <br />                                         immunization absence parasite persistence suggesting generation Ag-specific <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         memory cells. IFN-&#947; TNF-&#945; major cytokines involved clearance of <br />                                         intracellular pathogens like Leishmania, multifunctional cytokine producing cells are <br />                                         effective single cytokine secretory cells (37, 46, 61, 63). In current <br />                                         study immunization Ldp27&#8722;/&#8722; increased percent Leishmania specific CD4 and <br />                                         CD8 cells expressing Th1 cytokines (IFN&#947;, TNF&#945; IL-2) single multiple <br />                                         combinations response wild type parasite challenge. Importantly IFN&#947;+ TNF&#945;+ one <br />                                         major double cytokine producing cells Ldp27&#8722;/&#8722; immunized challenged mice <br />                                         observed protection L. major infections (60&#8211;61). From previous <br />                                         studies established CD8 T cells play potential role cure leishmaniasis <br />                                         particularly VL (5, 37, 64&#8211;66). In study observed significant <br />                                         numbers single multiple cytokine producing CD8 T cells immunized challenged <br />                                         mice confirming immunization live attenuated Ldp27&#8722;/&#8722; parasites, CD8 T cells <br />                                         play essential role host protection. Furthermore, significantly Leishmania antigen <br />                                         responsive CD8 T cells present immunized mice na&#239;ve mice. The protective <br />                                         function cells derive cytokine secretion cytotoxic activity. <br />                                         However, time analyzed cytotoxic function cells be <br />                                         focus future studies. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         We significantly increased IFN&#947;/ IL-10 ratio CD4 CD8 T cells in <br />                                         immunized infected mice compared non-immunized infected mice, suggesting <br />                                         polarization Th1 type cell development observed L. infantum infected <br />                                         mice immunization SIR2+/&#8722; (35). Further, co-production IFN&#947; IL-10 by <br />                                         antigen experienced CD4 CD8 T cells immunized infected mice suggests a <br />                                         desirable balance immune response allowing brief parasite persistence facilitates <br />                                         protection causing host damage (37). Therefore production multiple <br />                                         cytokine producing effector memory T cells T cells co-producing IFN-&#947; IL10 upon <br />                                         immunization Ldp27&#8722;/&#8722; parasites suggests used markers of <br />                                         immune correlates protection Ldp27&#8722;/&#8722; vaccine candidate. <br />  <br />                                         It debated persistence parasites pool central memory T cells is <br />                                         essential protective immunity reinfection Leishmania (67&#8211;69). In CL has <br />                                         reported that, anti-Leishmania memory cells develop infection maintained <br />                                         absence parasites, quality memory cells maintained presence <br />                                         absence live parasites different (68, 70). Our studies showed strong <br />                                         recall cellular immune response persistence attenuated parasites and <br />                                         absence attenuated parasites. However, observation short term <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         immunized mice higher level protection long term immunized mice suggests <br />                                         persistence pool effector cells rapidly respond infection where <br />                                         absence parasite persistence, serves source antigen, small <br />                                         pool central memory cells respond slowly infection transitioning effector <br />                                         memory cells eventually help controlling parasite burden. Therefore persistence <br />                                         parasite antigen antigen specific effector T cells probably effective than <br />                                         central memory cells alone. Further adoptive transfer experiments confirm generation of <br />                                         antigen specific CD4 CD8 T cells immunized mice confer protection <br />                                         re-infection wild type parasites. Future studies needed analyze type of <br />                                         T cells (potentially memory T cells) specific role live attenuated parasite <br />                                         immunization. <br />  <br />                                         Various Leishmania species different tissue tropism resulting different phenotypes. <br />                                         An ideal Leishmania vaccine control Leishmania <br />  <br />  <br />                                              J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                                                Page 12 <br />  <br />  <br />                                         infections. There reports shown cross protection L. major <br />                                         infections using parasite lysates defined proteins L. donovani (71&#8211;72). <br />                                         Additionally, L. donovani DNA vaccines L. infantum sterol 24-c-methyl-transferase <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         partial knock-out parasites induced strong protection L. mexicana L. major <br />                                         infections respectively (60, 73). Similarly, previous studies showed LdCen&#8722;/&#8722; <br />                                         parasite immunized mice cross-protected L. braziliensis infection (37). In this <br />                                         study Ldp27&#8722;/&#8722; immunized mice cross-protected L. major (CL) <br />                                         L. braziliensis (MCL) infections. All studies suggest efficacy a <br />                                         vaccine candidate depend quality cellular immunity antigen <br />                                         conservation species. Therefore, possible develop Leishmania vaccines <br />                                         especially live attenuated parasites provide opportunity broad based <br />                                         antigen repertoire immune respond cross protect infections <br />                                         Leishmania species. <br />  <br />                                         Overall study established Ldp27&#8722;/&#8722; live attenuated parasite potential <br />                                         vaccine candidate VL, CL MCL. However, significant differences in <br />                                         host immunity depending mode primary infections like needle inoculums vs sand <br />                                         fly mediated infections. Particularly CL, reported vaccine induced <br />                                         immunity confers protection needle challenge fails protect mice sand <br />                                         fly mediated infection (69, 74). These studies strongly suggest testing efficacy all <br />                                         Leishmania vaccines sand fly mediated infections. Recently developed a <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         rodent VL model sand fly vector mediated transmission (75). Vector-transmission <br />                                         generated slower progression VL resembled chronicity disease following <br />                                         natural transmission field. The slower progression disease relevant the <br />                                         evolution immunity infection pathogenesis. Therefore, slow progression of <br />                                         vector-initiated VL appropriate studies early immune events, parasite <br />                                         establishment, screening drugs vaccines. Such model allow test <br />                                         live attenuated vaccine candidates sand fly mediated L. donovani infections. <br />  <br />                                         In summary, results demonstrate immunization Ldp27&#8722;/&#8722; parasites provides a <br />                                         significant protection infection homologous heterologous species of <br />                                         Leishmania parasites. The immunization induced antigen specific strong multifunctional <br />                                         CD4 CD8 T cells correlates immune protection. Ldp27&#8722;/&#8722; parasites elicit memory <br />                                         response presence absence parasite persistence antigen specific <br />                                         cell mediated immunity correlated robust NO generation humoral response. Further <br />                                         Ldp27&#8722;/&#8722; parasites safe persist long time reducing the <br />                                         chance reversion wild type cause pathogenesis. Taken together, these <br />                                         studies strongly support Ldp27&#8722;/&#8722; mutant parasite safe effective immunogen <br />                                         potential vaccine broad spectrum leishmaniasis. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Supplementary Material <br />                                         Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                         We want thank Drs. Alain Debrabant, Sanjai Kumar Sreenivas Gannavaram critical review the <br />                                         manuscript. <br />  <br />                                         Source grants: The funding studies provided intramural funds Critical Path initiative of <br />                                         Center Biologics Evaluation Research, Food Drug Administration, USA. <br />  <br />  <br />  <br />  <br />                                                J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                                  Page 13 <br />  <br />  <br />                               References <br />                                         1. Desjeux P. Leishmaniasis: current situation new perspectives. Comp Immunol Microbiol Infect <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Dis. 2004; 27:305&#8211;318. [PubMed: 15225981] <br />                                         2. Desjeux P. Human leishmaniases: epidemiology public health aspects. World Health Stat Q. <br />                                            1992; 45:267&#8211;275. [PubMed: 1462660] <br />                                         3. Murray HW, Berman JD, Davies CR, Saravia NG. Advances leishmaniasis. Lancet. 2005; <br />                                            366:1561&#8211;1577. [PubMed: 16257344] <br />                                         4. Banuls AL, Bastien P, Pomares C, Arevalo J, Fisa R, Hide M. Clinical pleiomorphism human <br />                                            leishmaniases, special mention asymptomatic infection. Clin Microbiol Infect. 2011; <br />                                            17:1451&#8211;1461. [PubMed: 21933304] <br />                                         5. Kaye PM, Aebischer T. Visceral leishmaniasis: immunology prospects vaccine. Clin <br />                                            Microbiol Infect. 2011; 17:1462&#8211;1470. [PubMed: 21851483] <br />                                         6. Kaye P, Scott P. Leishmaniasis: complexity host-pathogen interface. Nat Rev Microbiol. <br />                                            2011; 9:604&#8211;615. [PubMed: 21747391] <br />                                         7. Harhay MO, Olliaro PL, Costa DL, Costa CH. Urban parasitology: visceral leishmaniasis Brazil. <br />                                            Trends Parasitol. 2011; 27:403&#8211;409. [PubMed: 21596622] <br />                                         8. Selvapandiyan A, Dey R, Gannavaram S, Lakhal-Naouar I, Duncan R, Salotra P, Nakhasi HL. <br />                                            Immunity visceral leishmaniasis using genetically defined live-attenuated parasites. J Trop Med. <br />                                            2012; 2012:631460. [PubMed: 21912560] <br />                                         9. Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, Coffman RL, Johnson WD, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Carvalho EM. Interleukin-12 restores interferon-gamma production cytotoxic responses in <br />                                            visceral leishmaniasis. J Infect Dis. 1996; 173:1515&#8211;1518. [PubMed: 8648233] <br />                                         10. Bacellar O, D&#8217;Oliveira A Jr, Jeronimo S, Carvalho EM. IL-10 IL-12 main regulatory <br />                                              cytokines visceral leishmaniasis. Cytokine. 2000; 12:1228&#8211;1231. [PubMed: 10930301] <br />                                         11. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM. Neutralization IL-12 <br />                                              demonstrates existence discrete organ-specific phases control Leishmania <br />                                              donovani. Eur J Immunol. 1998; 28:669&#8211;680. [PubMed: 9521077] <br />                                         12. Ghalib HW, Whittle JA, Kubin M, Hashim FA, Mel-Hassan A, Grabstein KH, Trinchieri G, Reed <br />                                              SG. IL-12 enhances Th1-type responses human Leishmania donovani infections. J Immunol. <br />                                              1995; 154:4623&#8211;4629. [PubMed: 7722314] <br />                                         13. Murray HW, Hariprashad J, Coffman RL. Behavior visceral Leishmania donovani an <br />                                              experimentally induced T helper cell 2 (Th2)-associated response model. J Exp Med. 1997; <br />                                              185:867&#8211;874. [PubMed: 9120392] <br />                                         14. Murray HW, Lu CM, Mauze S, Freeman S, Moreira AL, Kaplan G, Coffman RL. Interleukin-10 <br />                                              (IL-10) experimental visceral leishmaniasis IL-10 receptor blockade immunotherapy. <br />                                              Infect Immun. 2002; 70:6284&#8211;6293. [PubMed: 12379707] <br />                                         15. Mege JL, Meghari S, Honstettre A, Capo C, Raoult D. The faces interleukin 10 human <br />                                              infectious diseases. Lancet Infect Dis. 2006; 6:557&#8211;569. [PubMed: 16931407] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         16. Nylen S, Sacks D. Interleukin-10 pathogenesis human visceral leishmaniasis. Trends <br />                                              Immunol. 2007; 28:378&#8211;384. [PubMed: 17689290] <br />                                         17. Cummings HE, Tuladhar R, Satoskar AR. Cytokines STATs cutaneous visceral <br />                                              leishmaniasis. J Biomed Biotechnol. 2010; 2010:294389. [PubMed: 20300429] <br />                                         18. Silvestre R, Cordeiro-da-Silva A, Ouaissi A. Live attenuated Leishmania vaccines: potential <br />                                              strategic alternative. Arch Immunol Ther Exp (Warsz). 2008; 56:123&#8211;126. [PubMed: 18373245] <br />                                         19. Kedzierski L, Zhu Y, Handman E. Leishmania vaccines: progress problems. Parasitology. <br />                                              2006; 133(Suppl):S87&#8211;112. [PubMed: 17274851] <br />                                         20. Modabber F. Vaccines leishmaniasis. Ann Trop Med Parasitol. 1995; 89(Suppl 1):83&#8211;88. <br />                                              [PubMed: 8745930] <br />                                         21. Haldar JP, Ghose S, Saha KC, Ghose AC. Cell-mediated immune response Indian kala-azar and <br />                                              post-kala-azar dermal leishmaniasis. Infect Immun. 1983; 42:702&#8211;707. [PubMed: 6642649] <br />                                         22. Kamil <span id='am-148' about='obo:NCBITaxon_152839' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_4447 obo:NCBITaxon_4747 obo:NCBITaxon_158359 obo:NCBITaxon_158331 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_158350 obo:NCBITaxon_73496 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_1437197 obo:NCBITaxon_3193'><span id='am-149' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-150'  ></span><span id='am-151' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-152' property="rdfs:label" content="Aa" datatype="xsd:string"></span><span id='am-153' property="oboInOwl:hasRelatedSynonym" content="Aa Rchb.f." datatype="xsd:string"></span>AA</span>, Khalil EA, <span id='am-54' about='obo:NCBITaxon_4640' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_4447 obo:NCBITaxon_4734 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_4637 obo:NCBITaxon_131221 obo:NCBITaxon_4618 obo:NCBITaxon_58024 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_1437197 obo:NCBITaxon_3193'><span id='am-55' property="rdfs:label" content="Musa" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-57'  ></span><span id='am-58' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Musa</span> AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, <br />                                              Smith PG, Zicker F, El-Hassan AM. Alum-precipitated autoclaved Leishmania major plus bacille <br />                                              Calmette-Guerrin, candidate vaccine visceral leishmaniasis: safety, skin-delayed type <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                                   Page 14 <br />  <br />  <br />                                             hypersensitivity response dose finding healthy volunteers. Trans R Soc Trop Med Hyg. <br />                                             2003; 97:365&#8211;368. [PubMed: 15228261] <br />                                         23. Zijlstra EE, el-Hassan AM, Ismael A, Ghalib HW. Endemic kala-azar eastern Sudan: a <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             longitudinal study incidence clinical subclinical infection post-kala-azar dermal <br />                                             leishmaniasis. Am J Trop Med Hyg. 1994; 51:826&#8211;836. [PubMed: 7810819] <br />                                         24. Lauring AS, Jones JO, Andino R. Rationalizing development live attenuated virus vaccines. <br />                                             Nat Biotechnol. 2010; 28:573&#8211;579. [PubMed: 20531338] <br />                                         25. Svenson S, Kallenius G, Pawlowski A, Hamasur B. Towards new tuberculosis vaccines. Hum <br />                                             Vaccin. 2010; 6:309&#8211;317. [PubMed: 20372087] <br />                                         26. Larsen MH, Biermann K, Chen B, Hsu T, Sambandamurthy VK, Lackner AA, Aye PP, Didier P, <br />                                             Huang D, Shao L, Wei H, Letvin NL, Frothingham R, Haynes BF, Chen ZW, Jacobs WR Jr. <br />                                             Efficacy safety live attenuated persistent rapidly cleared <span id='am-11' about='obo:NCBITaxon_1763' typeof='obo:NCBITaxon_85007 owl:Thing obo:NCBITaxon_1762 obo:NCBITaxon_1 obo:NCBITaxon_1760 obo:NCBITaxon_131567 obo:NCBITaxon_2 obo:NCBITaxon_2037 obo:NCBITaxon_201174 obo:NCBITaxon_85003'><span id='am-12' property="oboInOwl:hasDbXref" content="PMID:1883713" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasRelatedSynonym" content="Mycobacterium Lehmann and Neumann 1896" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasDbXref" content="PMID:1380284" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="PMID:1581193" datatype="xsd:string"></span><span id='am-16'  ></span><span id='am-17' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasDbXref" content="PMID:7907223" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasDbXref" content="PMID:2275850" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasDbXref" content="PMID:7547284" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="PMID:7547304" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasDbXref" content="PMID:16014496" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasDbXref" content="PMID:8863452" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="Mycobacterium" datatype="xsd:string"></span>Mycobacterium</span> tuberculosis <br />                                             vaccine candidates non-human <span id='am-114' about='obo:NCBITaxon_9443' typeof='owl:Thing obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_7711 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_7742 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314146 obo:NCBITaxon_6072'><span id='am-115' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-116' property="rdfs:label" content="Primates" datatype="xsd:string"></span><span id='am-117' property="oboInOwl:hasRelatedSynonym" content="Primata" datatype="xsd:string"></span><span id='am-118' property="oboInOwl:hasRelatedSynonym" content="primates" datatype="xsd:string"></span><span id='am-119' property="oboInOwl:hasExactSynonym" content="primate" datatype="xsd:string"></span><span id='am-120'  ></span><span id='am-121' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>primates</span>. Vaccine. 2009; 27:4709&#8211;4717. [PubMed: 19500524] <br />                                         27. Alexander J, Coombs GH, Mottram JC. <span id='am-98' about='obo:NCBITaxon_5665' typeof='owl:Thing obo:NCBITaxon_38582 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-99' property="rdfs:label" content="Leishmania mexicana" datatype="xsd:string"></span><span id='am-100' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-101' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-102'  ></span><span id='am-103' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) mexicana" datatype="xsd:string"></span>Leishmania mexicana</span> cysteine proteinase-deficient <br />                                             mutants attenuated virulence mice potentiate Th1 response. J Immunol. 1998; <br />                                             161:6794&#8211;6801. [PubMed: 9862710] <br />                                         28. Gorczynski RM. Immunization susceptible BALB/c mice Leishmania braziliensis. I. <br />                                             Resistance induced using immunogen adherent nonadherent cells infected mice. Cell <br />                                             Immunol. 1985; 94:1&#8211;10. [PubMed: 3160485] <br />                                         29. Daneshvar H, Coombs GH, Hagan P, Phillips RS. Leishmania mexicana Leishmania major: <br />                                             attenuation wild-type parasites vaccination attenuated lines. J Infect Dis. 2003; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             187:1662&#8211;1668. [PubMed: 12721947] <br />                                         30. Kimsey PB, Theodos CM, Mitchen TK, Turco SJ, Titus RG. An avirulent lipophosphoglycan- <br />                                             deficient Leishmania major clone induces CD4+ T cells protect susceptible BALB/c mice <br />                                             infection virulent L. major. Infect Immun. 1993; 61:5205&#8211;5213. [PubMed: 7901166] <br />                                         31. Mitchell GF, Handman E, Spithill TW. Vaccination cutaneous leishmaniasis mice using <br />                                             nonpathogenic cloned promastigotes Leishmania major importance route injection. <br />                                             Aust J Exp Biol Med Sci. 1984; 62(Pt 2):145&#8211;153. [PubMed: 6466205] <br />                                         32. Rivier D, Shah R, Bovay P, Mauel J. Vaccine development cutaneous leishmaniasis. <br />                                             Subcutaneous administration radioattenuated parasites protects CBA mice virulent <br />                                             Leishmania major challenge. Parasite Immunol. 1993; 15:75&#8211;84. [PubMed: 8446467] <br />                                         33. Uzonna JE, Spath GF, Beverley SM, Scott P. Vaccination phosphoglycan-deficient <br />                                             Leishmania major protects highly susceptible mice virulent challenge inducing a <br />                                             strong Th1 response. J Immunol. 2004; 172:3793&#8211;3797. [PubMed: 15004184] <br />                                         34. Zhang WW, Matlashewski G. Characterization A2-A2rel gene cluster Leishmania <br />                                             donovani: involvement A2 visceralization infection. Mol Microbiol. 2001; 39:935&#8211; <br />                                             948. [PubMed: 11251814] <br />                                         35. Silvestre R, Cordeiro-Da-Silva A, Santarem N, Vergnes B, Sereno D, Ouaissi A. SIR2-deficient <br />                                             <span id='am-59' about='obo:NCBITaxon_5671' typeof='owl:Thing obo:NCBITaxon_38574 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-60' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasRelatedSynonym" content="Leishmania donovani infantum" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) infantum" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasAlternativeId" content="NCBITaxon:5662" datatype="xsd:string"></span><span id='am-64' property="rdfs:label" content="Leishmania infantum" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-66'  ></span>Leishmania infantum</span> induces defined IFN-gamma/IL-10 pattern correlates protection. J <br />                                             Immunol. 2007; 179:3161&#8211;3170. [PubMed: 17709531] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         36. Papadopoulou B, Roy G, Breton M, Kundig C, Dumas C, Fillion I, Singh AK, Olivier M, Ouellette <br />                                             M. Reduced infectivity Leishmania donovani biopterin transporter genetic mutant use <br />                                             attenuated strain vaccination. Infect Immun. 2002; 70:62&#8211;68. [PubMed: 11748164] <br />                                         37. Selvapandiyan A, Dey R, Nylen S, Duncan R, Sacks D, Nakhasi HL. Intracellular replication- <br />                                             deficient Leishmania donovani induces long lasting protective immunity visceral <br />                                             leishmaniasis. J Immunol. 2009; 183:1813&#8211;1820. [PubMed: 19592661] <br />                                         38. Dey R, Meneses C, Salotra P, Kamhawi S, Nakhasi HL, Duncan R. Characterization a <br />                                             Leishmania stage-specific mitochondrial membrane protein enhances activity of <br />                                             cytochrome c oxidase role virulence. Mol Microbiol. 2010; 77:399&#8211;414. [PubMed: <br />                                             20497506] <br />                                         39. Selvapandiyan A, Duncan R, Debrabant A, Bertholet S, Sreenivas G, Negi NS, Salotra P, Nakhasi <br />                                             HL. Expression mutant form Leishmania donovani centrin reduces growth the <br />                                             parasite. J Biol Chem. 2001; 276:43253&#8211;43261. [PubMed: 11544261] <br />  <br />  <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                                 Page 15 <br />  <br />  <br />                                         40. Debrabant A, Joshi MB, <span id='am-154' about='obo:NCBITaxon_260138' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_3931 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_41944 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_91836 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-155' property="rdfs:label" content="Pimenta" datatype="xsd:string"></span><span id='am-156' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-157' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-158'  ></span><span id='am-159' property="oboInOwl:hasRelatedSynonym" content="Pimenta Lindl." datatype="xsd:string"></span>Pimenta</span> PFP, Dwyer DM. Generation Leishmania donovani axenic <br />                                             amastigotes: growth biological characteristics. Intl J Parasitology. 2004; 34:205&#8211;217. <br />                                         41. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             control Leishmania major persistence immunity. Nature. 2002; 420:502&#8211;507. [PubMed: <br />                                             12466842] <br />                                         42. Selvapandiyan A, Duncan R, Mendez J, Kumar R, Salotra P, Cardo LJ, Nakhasi HL. A Leishmania <br />                                             minicircle DNA footprint assay sensitive detection rapid speciation clinical isolates. <br />                                             Transfusion. 2008; 48:1787&#8211;1798. [PubMed: 18564397] <br />                                         43. Rousseau D, Suffia I, Ferrua B, Philip P, Le Fichoux Y, Kubar JL. Prolonged administration of <br />                                             dexamethasone induces limited reactivation visceral leishmaniasis chronically infected <br />                                             BALB/c mice. Eur Cytokine Netw. 1998; 9:655&#8211;661. [PubMed: 9889410] <br />                                         44. Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, Scott P. Cysteine protease B of <br />                                             Leishmania mexicana inhibits host Th1 responses protective immunity. J Immunol. 2003; <br />                                             171:3711&#8211;3717. [PubMed: 14500670] <br />                                         45. Dey R, Sarkar A, Majumder N, Bhattacharyya Majumdar S, Roychoudhury K, Bhattacharyya S, <br />                                             Roy S, Majumdar S. Regulation impaired protein kinase C signaling chemokines murine <br />                                             macrophages visceral leishmaniasis. Infect Immun. 2005; 73:8334&#8211;8344. [PubMed: <br />                                             16299331] <br />                                         46. Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, <br />                                             Andersen P. Tuberculosis subunit vaccination provides long-term protective immunity <br />                                             characterized multifunctional CD4 memory T cells. J Immunol. 2009; 182:8047&#8211;8055. <br />                                             [PubMed: 19494330] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         47. Wei XQ I, Charles G, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY. <br />                                             Altered immune responses mice lacking inducible nitric oxide synthase. Nature. 1995; 375:408&#8211; <br />                                             411. [PubMed: 7539113] <br />                                         48. Carvalho EM, Teixeira RS, Johnson WD Jr. Cell-mediated immunity American visceral <br />                                             leishmaniasis: reversible immunosuppression acute infection. Infect Immun. 1981; 33:498&#8211; <br />                                             500. [PubMed: 7275314] <br />                                         49. Henao-Tamayo MI, Ordway DJ, Irwin SM, Shang S, Shanley C, Orme IM. Phenotypic <span id='am-170' about='obo:IAO_0000115' typeof='owl:Thing'>definition</span> <br />                                             effector memory T-lymphocyte subsets mice chronically infected Mycobacterium <br />                                             tuberculosis. Clin Vaccine Immunol. 2010; 17:618&#8211;625. [PubMed: 20107011] <br />                                         50. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, <br />                                             Ahmed R. Lineage relationship protective immunity memory CD8 T cell subsets. Nat <br />                                             Immunol. 2003; 4:225&#8211;234. [PubMed: 12563257] <br />                                         51. Nylen S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, Sacks D. Splenic accumulation IL-10 <br />                                             mRNA T cells distinct CD4+CD25+ (Foxp3) regulatory T cells human visceral <br />                                             leishmaniasis. J Exp Med. 2007; 204:805&#8211;817. [PubMed: 17389235] <br />                                         52. Flores-<span id='am-35' about='obo:NCBITaxon_316718' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_3646 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_235631 obo:NCBITaxon_3977 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_235892 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-36' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-38'  ></span><span id='am-39' property="rdfs:label" content="Garcia" datatype="xsd:string"></span>Garcia</span> Y, <span id='am-40' about='obo:NCBITaxon_3744' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91827 obo:NCBITaxon_71240 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-41' property="oboInOwl:hasAlternativeId" content="NCBITaxon:4266" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="Rosales" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasAlternativeId" content="NCBITaxon:3473" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasAlternativeId" content="NCBITaxon:3601" datatype="xsd:string"></span><span id='am-47'  ></span>Rosales</span>-Encina JL, Satoskar AR, Talamas-<span id='am-143' about='obo:NCBITaxon_442314' typeof='owl:Thing obo:NCBITaxon_37567 obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_82582 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_33415 obo:NCBITaxon_33317 obo:NCBITaxon_41191 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_37572 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_41196 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-144' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-145' property="rdfs:label" content="Rohana" datatype="xsd:string"></span><span id='am-146' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-147'  ></span>Rohana</span> P. IL-10-IFN-gamma double <br />                                             producers CD4+ T cells induced immunization amastigote stage specific derived <br />                                             recombinant protein <span id='am-67' about='obo:NCBITaxon_5693' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_47570 obo:NCBITaxon_5653'><span id='am-68' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-69'  ></span><span id='am-70' property="rdfs:label" content="Trypanosoma cruzi" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Trypanosoma cruzi</span>. Int J Biol Sci. 2011; 7:1093&#8211;1100. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             21927578] <br />                                         53. Bhowmick S, Mazumdar T, Ali N. Vaccination route induces transforming growth factor <span id='am-48' about='obo:NCBITaxon_3554' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_3563 obo:NCBITaxon_91827 obo:NCBITaxon_71240 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_3524 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_3193'><span id='am-49' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-50' property="rdfs:label" content="Beta" datatype="xsd:string"></span><span id='am-51'  ></span><span id='am-52' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasRelatedSynonym" content="Beta L. 1753" datatype="xsd:string"></span>beta</span> <br />                                             production fails elicit protective immunity Leishmania donovani infection. Infect <br />                                             Immun. 2009; 77:1514&#8211;1523. [PubMed: 19168736] <br />                                         54. Alexander J, Carter KC, Al-Fasi N, Satoskar A, Brombacher F. Endogenous IL-4 necessary for <br />                                             effective drug therapy visceral leishmaniasis. Eur J Immunol. 2000; 30:2935&#8211;2943. <br />                                             [PubMed: 11069076] <br />                                         55. Bruhn KW, Birnbaum R, Haskell J, Vanchinathan V, Greger S, Narayan R, Chang PL, Tran TA, <br />                                             Hickerson SM, Beverley SM, Wilson ME, Craft N. Killed metabolically active Leishmania <br />                                             infantum novel whole-cell vaccine visceral leishmaniasis. Clin Vaccine Immunol. 2012; <br />                                             19:490&#8211;498. [PubMed: 22323556] <br />                                         56. McFarlane E, Carter KC, McKenzie AN, Kaye PM, Brombacher F, Alexander J. Endogenous <br />                                             IL-13 plays crucial role liver granuloma maturation Leishmania donovani infection, <br />  <br />  <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                                  Page 16 <br />  <br />  <br />                                             independent IL-4Ralpha-responsive macrophages neutrophils. J Infect Dis. 2011; 204:36&#8211; <br />                                             43. [PubMed: 21628656] <br />                                         57. Stager S, Alexander J, Carter KC, Brombacher F, Kaye PM. Both interleukin-4 (IL-4) IL-4 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             receptor alpha signaling contribute development hepatic granulomas optimal <br />                                             antileishmanial activity. Infect Immun. 2003; 71:4804&#8211;4807. [PubMed: 12874364] <br />                                         58. Murray HW, Tsai CW, Liu J, Ma X. Visceral Leishmania donovani infection interleukin-13&#8722;/&#8722; <br />                                             mice. Infect Immun. 2006; 74:2487&#8211;2490. [PubMed: 16552085] <br />                                         59. Coler RN, Goto Y, Bogatzki L, Raman V, Reed SG. Leish-111f, recombinant polyprotein <br />                                             vaccine protects visceral Leishmaniasis elicitation CD4+ T cells. Infect Immun. <br />                                             2007; 75:4648&#8211;4654. [PubMed: 17606603] <br />                                         60. Goto Y, <span id='am-138' about='obo:NCBITaxon_706860' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_30102 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_35567 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_7524 obo:NCBITaxon_6960 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_33372 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33365 obo:NCBITaxon_33342 obo:NCBITaxon_33368 obo:NCBITaxon_50557'><span id='am-139' property="rdfs:label" content="Bhatia" datatype="xsd:string"></span><span id='am-140' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-141' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-142'  ></span>Bhatia</span> A, Raman VS, Vidal SE, Bertholet S, Coler RN, Howard RF, Reed SG. <br />                                             Leishmania infantum sterol 24-c-methyltransferase formulated MPL-SE induces cross- <br />                                             protection L. major infection. Vaccine. 2009; 27:2884&#8211;2890. [PubMed: 19428898] <br />                                         61. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, <br />                                             Reed SG, Morris SL, Roederer M, Seder RA. Multifunctional TH1 cells define correlate of <br />                                             vaccine-mediated protection Leishmania major. Nat Med. 2007; 13:843&#8211;850. [PubMed: <br />                                             17558415] <br />                                         62. Kaveh DA V, Bachy S, Hewinson RG, Hogarth PJ. Systemic BCG immunization induces <br />                                             persistent lung mucosal multifunctional CD4 T(EM) cells expand following virulent <br />                                             mycobacterial challenge. PLoS One. 2011; 6:e21566. [PubMed: 21720558] <br />                                         63. Bogdan C, Moll H, Solbach W, Rollinghoff M. Tumor necrosis factor-alpha combination with <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             interferon-gamma, interleukin 4 activates murine macrophages elimination of <br />                                             Leishmania major amastigotes. Eur J Immunol. 1990; 20:1131&#8211;1135. [PubMed: 2113475] <br />                                         64. Joshi T, Rodriguez S, Perovic V, Cockburn <span id='am-6' about='obo:NCBITaxon_360966' typeof='owl:Thing obo:NCBITaxon_9397 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_117570 obo:NCBITaxon_32524 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_9431 obo:NCBITaxon_314145 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_30560 obo:NCBITaxon_7776 obo:NCBITaxon_9347'><span id='am-7' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="Ia" datatype="xsd:string"></span><span id='am-9'  ></span><span id='am-10' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>IA</span>, Stager S. B7-H1 blockade increases survival of <br />                                             dysfunctional CD8(+) T cells confers protection Leishmania donovani infections. <br />                                             PLoS Pathog. 2009; 5:e1000431. [PubMed: 19436710] <br />                                         65. Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, Bertholet S, Udey MC, Sacks D. CD8+ T <br />                                             cells required primary immunity C57BL/6 mice following low-dose, intradermal <br />                                             challenge Leishmania major. J Immunol. 2002; 168:3992&#8211;4000. [PubMed: 11937556] <br />                                         66. Stager S, Rafati S. CD8(+) T cells leishmania infections: friends foes? Front Immunol. 2012; <br />                                             3:5. [PubMed: 22566891] <br />                                         67. Seder RA, Sacks DL. Memory need reminding. Nat Med. 2004; 10:1045&#8211;1047. [PubMed: <br />                                             15459703] <br />                                         68. Zaph C, Uzonna J, Beverley SM, Scott P. Central memory T cells mediate long-term immunity to <br />                                             Leishmania major absence persistent parasites. Nat Med. 2004; 10:1104&#8211;1110. [PubMed: <br />                                             15448686] <br />                                         69. Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL. Vector transmission of <br />                                             leishmania abrogates vaccine-induced protective immunity. PLoS Pathog. 2009; 5:e1000484. <br />                                             [PubMed: 19543375] <br />                                         70. Okwor I, Uzonna J. Persistent parasites immunologic memory cutaneous leishmaniasis: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             implications vaccine designs vaccination strategies. Immunol Res. 2008; 41:123&#8211;136. <br />                                             [PubMed: 18389179] <br />                                         71. Rachamim N, Jaffe CL. Pure protein Leishmania donovani protects mice both <br />                                             cutaneous visceral leishmaniasis. J Immunol. 1993; 150:2322&#8211;2331. [PubMed: 8450215] <br />                                         72. Tonui WK, Titus RG. Cross-protection Leishmania donovani L. Braziliensis caused <br />                                             vaccination L. Major soluble promastigote exogenous antigens BALB/c mice. Am J <br />                                             Trop Med Hyg. 2007; 76:579&#8211;584. [PubMed: 17360887] <br />                                         73. Aguilar-Be I, da Silva Zardo R, Paraguai Souza E, Borja-Cabrera GP, Rosado-Vallado M, Mut- <br />                                             Martin M, Garcia-Miss R, del M, Palatnik <span id='am-165' about='obo:NCBITaxon_103599' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_91561 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_117570 obo:NCBITaxon_32524 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314145 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_9721 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_9722 obo:NCBITaxon_9726'><span id='am-166'  ></span><span id='am-167' property="rdfs:label" content="Sousa" datatype="xsd:string"></span><span id='am-168' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-169' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Sousa</span> CB, Dumonteil E. Cross-protective efficacy of <br />                                             prophylactic Leishmania donovani DNA vaccine visceral cutaneous murine <br />                                             leishmaniasis. Infect Immun. 2005; 73:812&#8211;819. [PubMed: 15664920] <br />                                         74. Rogers ME, Sizova OV, Ferguson MA, Nikolaev AV, Bates PA. Synthetic glycovaccine protects <br />                                             bite leishmania-infected sand flies. J Infect Dis. 2006; 194:512&#8211;518. [PubMed: <br />                                             16845636] <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                            Page 17 <br />  <br />  <br />                                         75. Aslan H, Dey R, Meneses C, Castrovinci P, Jeronimo S, <span id='am-1' about='obo:NCBITaxon_57634' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_57613 obo:NCBITaxon_57612 obo:NCBITaxon_33154 obo:NCBITaxon_1206795 obo:NCBITaxon_69555 obo:NCBITaxon_6447 obo:NCBITaxon_33317 obo:NCBITaxon_6448 obo:NCBITaxon_2759 obo:NCBITaxon_6479 obo:NCBITaxon_216293 obo:NCBITaxon_6072'><span id='am-2' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-3'  ></span><span id='am-4' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="Oliva" datatype="xsd:string"></span>Oliva</span> G, Fischer L, Duncan R, Nakhasi <br />                                             HL, <span id='am-109' about='obo:NCBITaxon_186129' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_38127 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_239228 obo:NCBITaxon_298052 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_159975 obo:NCBITaxon_6960 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_30259 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33342 obo:NCBITaxon_50557'><span id='am-110' property="rdfs:label" content="Valenzuela" datatype="xsd:string"></span><span id='am-111'  ></span><span id='am-112' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-113' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Valenzuela</span> J, Kamhawi S. A New Model Progressive Visceral Leishmaniasis Hamsters <br />                                             Natural Transmission Bites Vector Sand Flies. J Infect Dis. 2012 In press. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                          Page 18 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Figure 1. <br />                                         Avirulent properties p27 knockout L. donovani (Ldp27&#8722;/&#8722;) parasite BALB/c mice. <br />                                         Survival wild type (Wt) Ldp27&#8722;/&#8722; parasites Liver (A) Spleen (B) BALB/c <br />                                         mice. Mice infected Wt Ldp27&#8722;/&#8722; parasites, 4, 8 16 weeks (ws) post- <br />                                         infection (PI) parasite load infected mice measured. (C) Effect immunosuppressive <br />                                         drug Dexamethasone (DXM) infected mice. Parasite load measured spleen of <br />                                         mice infected Wt p27&#8722;/&#8722; parasite different weeks post-infection treated <br />                                         DXM. (D) Histopathology liver Wt Ldp27&#8722;/&#8722; infected mice 6 weeks <br />                                         16 weeks post-infection. Black arrows pointing infection foci intra-cellular parasites. <br />                                         The data presented representative independent experiments similar results <br />                                         4 mice group. Mean SEM group shown. *, p &lt; 0.05. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                       Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Figure 2. <br />                                         Protection Ldp27&#8722;/&#8722; parasite immunization L. donovani infection. Mice were <br />                                         immunized Ldp27&#8722;/&#8722; parasites PBS, 12 weeks post-immunized mice <br />                                         challenged Wt parasites. Parasite number Liver (A) Spleen (B) was <br />                                         measured 4 weeks, 8 weeks 12 weeks post- infection. Mean SEM mice in <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         group shown. (C) Long term effect immunization. 20 weeks post-immunized <br />                                         mice challenged Wt parasites 12 weeks infection parasite burden was <br />                                         determined. The data representation independent experiments similar <br />                                         results 4- 5 mice group. Mean SEM group shown. PI, post- <br />                                         immunization; PC, post-challenge *, p &lt; 0.05 **, p &lt; 0.01. <br />  <br />  <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                       Page 20 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Figure 3. <br />                                         Leishmania antigen stimulated cytokine profiles splenocyte culture supernatants from <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         na&#239;ve, Ldp27&#8722;/&#8722; immunized (Imm), na&#239;ve challenged (Na&#239;ve Chal) Ldp27&#8722;/&#8722; immunized <br />                                         challenged (Imm Chal) mice. 12 20 weeks post immunized mice challenged with <br />                                         wild type parasite 3 weeks post challenge mice euthanized (shown bar <br />                                         diagram) spleens collected. Concentration cytokines culture supernatants <br />                                         measured using multiplex mouse cytokine kit described Materials &amp; Methods <br />                                         section. The data presented representative independent experiments similar <br />                                         results. Mean SEM group shown. *, p &lt; 0.05 **, p &lt; 0.01. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                         Page 21 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Figure 4. <br />                                         Immunization Ldp27&#8722;/&#8722; induces Nitric Oxide (NO) production splenocyte. The <br />                                         activity NOS2 indicated released nitrite antigen stimulated <br />                                         splenocytes supernatants (48 hrs) measured Griess reaction. The data <br />                                         presented representative experiments similar results 4&#8211;5 mice each <br />                                         group. Mean SEM mice group shown. PI, post- <br />                                         immunization; PC, post-challenge * p&lt; 0.05; ** p &lt; 0.01 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               J Immunol. Author manuscript; available PMC 2014 March 01. <br />                             Dey et al.                                                                                      Page 22 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Figure 5. <br />                                         Proliferative capacity Ag-specific T cells 20 <br /> </body></html>